NCT00001266View on ClinicalTrials.gov

A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

October 31, 1990

Study Completion Date

August 31, 2003

Conditions

Prostatic Neoplasm

Interventions

DRUG

Suramin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH